XML 17 R8.htm IDEA: XBRL DOCUMENT
v3.24.3

Basis of preparation and statement of compliance | 6 Months Ended
--- | ---
Jun. 30, 2024
Basis of preparation and statement of compliance |
Basis of preparation and statement of compliance | Note 2. Basis of preparation and statement of compliance 2.1.Basis of preparation for the consolidated financial statements The Company has prepared these unaudited interim condensed consolidated financial statements in accordance with International Financial Reporting Standards (“IFRS”) as adopted by the European Union and IFRS Accounting Standards as issued by the International Accounting Standard Board (“IASB”). These unaudited interim condensed consolidated financial statements as of June 30, 2024 were approved by the Board of Directors of the Company on 14 October, 2024. 2.2. Statement of compliance These unaudited interim condensed consolidated financial statements were prepared in compliance with International Accounting Standards (IAS) 34 — Interim Financial Reporting, which provides for the presentation of selected explanatory notes. The accompanying notes do not contain all the disclosures required for annual financial statements and should therefore be read in conjunction with the Company’s financial statements prepared in accordance with IFRS ®Accounting Standards, referred to as IFRS as of and for the year ended December 31, 2023 except for the accounting principles described in Note 3 – Accounting principles. IFRS Accounting Standards basis adopted The accounting policies applied by the Company in the preparation of the unaudited interim condensed consolidated financial statements for the six-month period ended June 30, 2024, are identical to those used in the annual financial statements prepared in accordance with IFRS Accounting Standards as of and for the year ended December 31, 2023, with the exception of specific provisions for the preparation of unaudited interim condensed consolidated financial statements. Standards, amendments to existing standards and interpretations published by the IASB whose application has been mandatory since January 1, 2024 The application of standards, amendments to existing standards and interpretations whose application has been mandatory since January 1, 2024 in the European Union primarily concern:
| - | Amendment to IFRS 16 – Lease liability in a sale and leaseback
| - | Amendment to IAS 1 – Non-current liabilities with covenants
| - | Amendment to IAS 7 and IFRS 7 – Supplier finance arrangements
Those amendments had no material impact on the Company’s unaudited interim condensed consolidated financial statements for the six-month period ended June 30, 2024. As of June 30, 2024, the IASB had not published any amendments that would be expected to have a material impact on the Company’s consolidated financial statements. Standards, amendments to existing standards and interpretations published by the IASB whose application is not yet mandatory The new standards, interpretations and amendments to existing standards that have been published but are not yet applicable concern:
| - | Amendments to IAS 21 – Lack of Exchangeability
| - | Amendment to IFRS 9 and IFRS 7 – Classification and Measurement of Financial Instruments
| - | New Standard – IFRS 18 – Presentation and Disclosure in Financial Statements
| - | New standard – IFRS 19 Subsidiaries without Public Accountability: Disclosures
These new standards, interpretations and amendments are under analysis to see if there are applicable to Inventiva. 2.3. Scope and method of consolidation
| ● | Accounting policy
In accordance with IFRS 10 Consolidated Financial Statements, an entity (subsidiary) is consolidated when it is controlled by the company (the parent). Subsidiaries are all entities over which the Company has control. The Company controls an entity when it is exposed to, or has rights to, variable returns from its involvement with the entity and could affect those returns through its power to direct the activities of the entity. Subsidiaries are consolidated from the date on which control is transferred to the Company. They are deconsolidated from the date such control ceases. All intercompany transactions, balances, and unrealized gains on transactions between group companies are eliminated. Unrealized losses are also eliminated unless the transaction provides evidence of an impairment of the transferred asset. Accounting policies of subsidiaries are consistent with the policies adopted by the Company.
| ● | Consolidated entities
As of June 30, 2024, the scope of consolidation consists of two entities, the parent, Inventiva S.A. and its 100% owned subsidiary, Inventiva Inc., for which no non-controlling interest is recognized.
​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ |  | Percent of |  | ​
​ | ​ | Date of | ​ | Ownership | ​ | ​
​ | ​ | incorporation | ​ | Interest | ​ | Accounting Method
INVENTIVA Inc. |  | 01/05/2021 |  | 100 | % | Fully Consolidated
​
| ● | Interests in associates and joint ventures
Hepalys is incorporated and has its principal place of business in Japan. The Company’s proportion of ownership interest is 14.6% and is the same as the proportion of voting rights held. In accordance with IAS 28 Investments in Associates and Joint Ventures, Hepalys is an associate of the Company and is accounted for using the equity method (see Note 4.4. – Investments accounted for using the equity method). 2.4Foreign currency translation
| ● | Functional and presentation currency
The Company’s consolidated financial statements are presented in euros, which is also the functional currency of the parent company, Inventiva S.A. The functional currency of Inventiva Inc. is the U.S. dollar. All amounts presented in these notes to the consolidated financial statements are denominated in euros unless otherwise stated.
| ● | Translation of financial statements into presentation currency
The results and financial position of foreign operations that have a functional currency different from the presentation currency are translated into euros, the presentation currency, as follows:
| ● | Assets and liabilities for each balance sheet presented are translated at the closing rate on the date of that balance sheet,
| ● | Income and expenses for each statement of (income) loss and statement of comprehensive (income) loss are translated at average exchange rates (which is an approximate value of the exchange rate on the transaction date in the absence of significant fluctuations. Income and expenses are translated at the transaction dates if the exchange rates fluctuate significantly), and
| ● | All resulting exchange differences are recognized in other comprehensive income.
​
​ | ​ | ​ | ​ | ​ | ​ | ​
Exchange rate (USD per EUR) |  | As of June 30, 2024 |  | As of December 31, 2023 |  | As of June 30, 2023
Average exchange rate for the period |  | 1.0813 | ​ | 1.0803 | ​ | 1.0807
Exchange rate at period end |  | 1.0705 | ​ | 1.1050 | ​ | 1.0866
​

X
- Definition An explicit and unreserved statement of compliance with all the requirements of IFRSs. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2023-01-01 -Paragraph 16 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_16&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_StatementOfIFRSCompliance
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition N/A + References No definition available. + Details
Name: | iva_StatementOfComplianceAbstract
Namespace Prefix: | iva_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration